William Blair & Company’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-37,000
Closed -$133K 1830
2019
Q3
$133K Sell
37,000
-100
-0.3% -$359 ﹤0.01% 1347
2019
Q2
$99K Sell
37,100
-18,500
-33% -$49.4K ﹤0.01% 1425
2019
Q1
$165K Buy
55,600
+1,000
+2% +$2.97K ﹤0.01% 1339
2018
Q4
$87K Sell
54,600
-2,300
-4% -$3.67K ﹤0.01% 1336
2018
Q3
$209K Buy
56,900
+1,000
+2% +$3.67K ﹤0.01% 1278
2018
Q2
$158K Buy
55,900
+400
+0.7% +$1.13K ﹤0.01% 1296
2018
Q1
$206K Hold
55,500
﹤0.01% 1197
2017
Q4
$160K Buy
55,500
+100
+0.2% +$288 ﹤0.01% 1283
2017
Q3
$249K Sell
55,400
-6,800
-11% -$30.6K ﹤0.01% 1186
2017
Q2
$285K Buy
62,200
+22,800
+58% +$104K ﹤0.01% 1189
2017
Q1
$158K Sell
39,400
-3,000
-7% -$12K ﹤0.01% 1219
2016
Q4
$175K Buy
42,400
+3,500
+9% +$14.4K ﹤0.01% 1155
2016
Q3
$315K Buy
38,900
+1,500
+4% +$12.1K ﹤0.01% 985
2016
Q2
$292K Sell
37,400
-25,900
-41% -$202K ﹤0.01% 993
2016
Q1
$488K Buy
63,300
+22,900
+57% +$177K ﹤0.01% 799
2015
Q4
$435K Sell
40,400
-35,600
-47% -$383K ﹤0.01% 847
2015
Q3
$525K Sell
76,000
-71,630
-49% -$495K ﹤0.01% 960
2015
Q2
$1.31M Buy
147,630
+103,130
+232% +$914K ﹤0.01% 1496
2015
Q1
$438K Buy
44,500
+29,500
+197% +$290K ﹤0.01% 1750
2014
Q4
$183K Buy
15,000
+3,000
+25% +$36.6K ﹤0.01% 1973
2014
Q3
$119K Buy
+12,000
New +$119K ﹤0.01% 2007
2014
Q2
Sell
-16,800
Closed -$55K 2119
2014
Q1
$55K Buy
16,800
+700
+4% +$2.29K ﹤0.01% 1973
2013
Q4
$53K Sell
16,100
-1,400
-8% -$4.61K ﹤0.01% 1941
2013
Q3
$52K Hold
17,500
﹤0.01% 1983
2013
Q2
$143K Buy
+17,500
New +$143K ﹤0.01% 1858